The quest for novel chemical matter and the contribution of computer-aided de novo design

Expert Opinion on Drug Discovery

Volumn 6, Issue 3, 2011, Pages 225-231

  Pirard, Bernard ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

de novo design; fragment space; hit finding; multi objective scoring; natural computing; scoring

Indexed keywords

CYCLIN DEPENDENT KINASE 2 INHIBITOR;

ALGORITHM; COMPUTER AIDED DE NOVO DESIGN; COMPUTER AIDED DESIGN; COMPUTER MODEL; HUMAN; MEDICAL RESEARCH; MOLECULE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; STRUCTURE ANALYSIS; VALIDATION PROCESS;

EID: 79952221121     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.2011.554394     Document Type: Review

References (34)

1. Perola E. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs. J Med Chem 2010;53:2986-97
2. Walters WP, Namchuk M. Designing screens: how to make your hits a hit. Nat Rev Drug Discov 2003;2:259-66 (Pubitemid 37361684)
3. Congreve M, Chessari G, Tisi G, et al. Recent developments in fragment-based drug discovery. J Med Chem 2008;51:3661-80 (Pubitemid 351956496)
4. Bleicher KH, Bohm H-J, Muller K, et al. Hit and lead generation: beyond high throughput screening. Nat Rev Drug Discov 2003;2:369-78 (Pubitemid 37361707)
5. Schneider G, Fechner U. Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov 2005;4:649-63 (Pubitemid 41149759)
6. Baber JC, Feher M. Predicting synthetic accessibility: application in drug discovery and development. Mini Rev Med Chem 2004;4:681-92 (Pubitemid 38961233)
7. Loving K, Alberts I, Sherman W. Computational approaches for fragment-based and de novo design. Curr Top Med Chem 2010;10:14-32
8. Mauser H, Stahl M. Chemical fragment spaces for de novo design. J Chem Inf Model 2007;47:318-24 (Pubitemid 46615936)
9. Degen J, Wegscheid-Gerlach C, Zaliani A, et al. On the art of compiling and using 'drug-like' chemical fragment spaces. ChemMedChem 2008;3:1503-7
10. Lewell XQ, Judd DB, Watson SP, et al. Recap retrosynthetic combinatorial analysis procedure, a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci 1998;38:511-22 (Pubitemid 128594467)
11. Patel H, Bodkin MJ, Chen B, et al. Knowledge-based approach to de novo design using reaction vectors. J Chem Inf Model 2009;49:1163-84
12. Hiss JA, Hartenfeller M, Schneider G. Concepts and applications of "natural computing" techniques in de novo drug and peptide design. Curr Pharm Des 2010;16:1656-65
13. Gohlke H, Klebe G. Approaches to the description and prediction of the binding affinity of small-molecules ligands to macromolecular receptors. Angew Chem Int Ed 2002;41:2644-76
14. Stahura FL, Bajorath J. New methodologies for ligand-based virtual screening. Curr Pharm Des 2005;11:1189-202 (Pubitemid 40403377)
15. Erickson JA, Mader MM, Watson IA, et al. Structure-guided expansion of kinase fragment libraries driven by support vector machine models. Biochimica et Biophysica Acta 2010;1804:642-52
16. Gasteiger J, Ihlefnfeldt WD. Computer-assisted planning of organic syntheses: the second generation of programs. Angew Chem Int Ed Eng 1996;34:2613-33 (Pubitemid 126675729)
17. Gillet VJ, Myatt G, Zsoldos Z, et al. SPROUT, HIPPo and CAESA: tools for de novo structure generation and estimation of synthetic accessibility. Perspect Drug Disc Design 1995;3:34-50
18. Ertl P, Schuffenhauer A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J Cheminformatics 2009;1:8
19. Dey F, Caflisch A. Fragment-based de novo design by multiobjective evolutionary optimization. J Chem Inf Model 2008;48:679-90 (Pubitemid 351535435)
20. Nicolaou C, Apostolakis J, Pattichis CS. De novo drug design using multiobjective evolutionary graphs. J Chem Inf Model 2009;49:295-307
21. Mauser H, Guba W. Recent developments in de novo design and scaffold hopping. Curr Opin Drug Discov Devel 2008;11:365-74 (Pubitemid 351572446)
22. Damewood Jr JR, Lerman CL, Masek BB. NovoFLAP: a ligand-based de novo design approach for the generation of medicinally relevant ideas. J Chem Inf Model 2010;50:1296-303
23. Zaliani A, Boda K, Seidel T, et al. Second-generation de novo design: a view from a medicinal chemist perspective. J Comput Aided Mol Des 2009;23:593-602
24. Alig L, Alsenz J, Andjelkovic M, et al. Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity. J Med Chem 2008;51:2115-27 (Pubitemid 351503267)
25. Proschak E, Sander K, Zettl H, et al. From molecular shape to potent bioactive agents II: fragment-based de novo design. ChemMedChem 2009;4:45-8
26. Lo HY, Bentzien J, White A, et al. 2-Aminobenzimidazoles as potent ITK antagonists: de novo design of a pyrrole system targeting additional hydrogen bonding interaction. Tetrahedron Lett 2008;49:7337-40
27. Li W-W, Chen J-J, Zeng R-L, et al. Taking quinazoline as a general support-nog to design potent and selective kinase inhibitors: application to FMS-like tyrosine kinase 3. ChemMedChem 2010;5:513-16
28. Park H, Bahn YJ, Ryu SE. Structure-based de novo design and biochemical evaluation of novel cdc25 phosphatase inhibitors. Bioorg Med Chem Lett 2009;19:4330-4
29. Guo C, Hou X, Dong L, et al. Structure-based design of novel human Pin1 inhibitors. Bioorg Med Chem Lett 2009;19:5613-16
30. Wang R, Gao Y, Lai L. LigBuilder: a multi-purpose program for structure-based drug design. J Mol Model 2000;6:498-516
31. Perot S, Sperandio O, Miteva MA, et al. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov Today 2010;15:656-67
32. Hartenfeller M, Proschak E, Schuller A, et al. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization. Chem Biol Drug Des 2008;72:16-26 (Pubitemid 351852775)
33. Huang Q, Li L-N, Yang S-Y. PHDD: a new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility. J Mol Graphics Model 2010;28:775-87
34. Pfeffer P, Fober T, Hullermeier E, et al. GARLig: a fully automated tool for subset selection of large fragment spaces via a self-adaptative genetic algorithm. J Chem Inf Model 2010;50:1644-59